Evofem Biosciences (EVFM) Misses Q2 EPS by 2c

Evofem Biosciences (OTC: EVFM) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $4.8 million.

For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Varonis Systems (VRNS) call put ratio 5.1 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 9%
• ACM Research, Inc. (ACMR) PT Raised to $130 at Morgan Stanley